Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3342370 | 0.88 | APP (0.35) | — | |
| SCHEMBL15631777 | 0.84 | — | — | |
| SCHEMBL27455553 | 0.82 | APP (0.31) | — | |
| SCHEMBL8763042 | 0.82 | PTGS1 (0.30) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL742679 | 0.81 | USP2 (0.33) | LMNA | |
| Ammonia Solution, Strong SCHEMBL18139365 | 0.80 | — | — | |
| SCHEMBL19547658 | 0.79 | THRB (0.33) | LMNA | |
| SCHEMBL18906952 | 0.78 | GRIN2D (0.38) | — | |
| SCHEMBL19220237 | 0.77 | — | — | |
| SCHEMBL11964294 | 0.73 | HSD11B1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005856-B2 | Curable composition | FUJIFILM CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152331-A1 | CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF | ASH2L, VMA21, SGMS1 | PTGS1 1781/4885PDE4A 4739/4885LMNA 2640/4885 |
| US-10005856-B2 | Curable composition | ASH2L, ASH1L, CHRM1 | PTGS1 2414/4885PDE4A 4806/4885LMNA 2217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.